Feb 14, 2024
 in 
Hot Stocks 🔥

Diabetes and weight loss drug market expected to soar to $100bn by 2030

Name of opportunity: 👀

Novo Nordisk A/S 

Flying off the shelves: 💸

Analysts say the diabetes and weight loss market will be worth $100bn by 2030, which means Novo Nordisk A/S could be a great investment. The pharmaceutical company’s product range includes Saxenda, their brand name for liraglutide, a drug similar to Ozempic. 

This type of drug has seen enormous popularity over the last year. While often used as a treatment for type 2 diabetes, its use as a weight loss drug has everyone talking. This product has been flying off shelves around the world at such a speed that some countries are running low on supplies, which just goes to show how popular this drug is. 

How hot is this investment opportunity? 🔥🔥🔥

Analysts see it as a Buy.

Novo Nordisk A/S has steadily risen in value over the last year. 

Analysts predict that Novo Nordisk A/S will increase in value over the next 12 months by 1.98%, from $120.38 to $122.81. 

Snapshot of the company: 📸

This is a solid company with a very long history, dating back to the 1920s when Nordisk Insulinlaboratorium started commercially producing insulin. 

The value of Novo Nordisk hit a new record high in 2023. Since then, through a $16.5bn deal, Novo Nordisk has acquired three sites previously owned by pharma manufacturers Catalent in order to increase production. It seems they are feeling confident and aiming to scale - suggesting this could be a great time to invest. 

Which neme?: 🔍

You can find this stock in the Pharma neme.

Han Tan

Han Tan is a seasoned financial journalist and news presenter renowned for his expertise in global markets. With a career highlighted by interviews with prominent figures and recognition from major media outlets like CNN and Reuters, he delivers insightful analysis on market news and macroeconomic trends to clients and international audiences. Han's sharp commentary on currencies, stocks, and commodities is familiar to viewers of Bloomberg TV Malaysia, BFM 89.9, and NTV7, cementing his sterling reputation in the industry.